Member Info for Saint68

Don't think LSE let you post links until you've made the minimum amount of posts necessary. I'll check out the video on Twitter later :-)

Strange that they have a different surname then.

Hi Les and thanks for the reply. I agree it’s definitely someone who’s been here before but hopefully they’ll behave this time and maybe add something positive to the discussions.
Cheers, Saint.

Hi Les. I read the posts and thought they were balanced. What do you have an issue with and have I missed something ? Would prefer to read something constructive rather than a load of he said / she said.

Excellent series of posts SirVical1. Summed everything up well and very reasoned. So much better to read than a lot of the bickering we see here too often. I too think that you used to post here previously but will stop short of who I think you could be. Good luck with your investment.

Yes it is. Things seem to be moving along nicely.

Agreed and hopefully I'll be able to top up here if things work out elsewhere :-)

Indeed Ivy. I believe AVACT raised at £1.20 so for me anything under that is a good opportunity. This along with all the collaborations / milestone payments has enforced my belief. I'm also in HEMO. Very undervalued IMO and the SP woe's were caused by a foolish agreement with Mint capital and CLN's. Those have now been confined to history and the company has a few shots at goal. Some very good appointments lately and In collaboration with Penn Uni. Hopefully into clinical trials with their Car-T therapy by year end. CEO has stated that they have enough cash to see them through 2023. RM a very good endorsement for everyone here.

Thanks BOJO. All funds tied up at the moment but will definitely take a look should the situation change. Cheers.

Hi Ivy. Yes that's probably it. Yes some people treat Myles like the Messiah and with his large following he definitely has influence. A lot of the stuff he posts is very good but you can take an educated guess as to when he's trading a little. I tend to listen then research as much as I can. I averaged down massively there when it dropped to around 45p a while back so am happy with my holding. I have great hope for both companies and am happy to ride the waves.

No worries Ruck. Agreed - I'm trying to get away from the one trick pony trap too. Happy to learn from more knowledgeable holders here.

* looking forward. Fat fingers syndrome.

Hi all. Don't post here much but have been an avid reader for quite some time. I have interests in both companies and I have to disagree that Avactas share price reacts more on news. They have been running clinical trials at several centres for nearly 12 months and we've only had good news. In this time we've had 2 dose escalations and are currently using a dose higher than the standard Doxorubicin with no maximum tolerated dose found. We're due an update in Q3 22 and if everything is progressing as expected a re-rate could be on the card (hopefully). The share price however has dropped and I really can't understand why - aside from the LFT debacle.
I'm hoping both companies come good - firstly for the benefit of patients and also for shareholders.
Good luck to all and looking for the next update here.

Zoros - I think it's tomorrow night British Time - 19th in Oz.

Some excellent debates / info on here tonight. Thanks to LB, Mac and Caw.

Since when has no licenses been a fact ? - back to school for you.

Excellent post LB and I agree that the NYUD license is the key and also that we’re looking at November at the earliest to hear any definitive sale news.

Reported and binned

From GMF on Twitter. $3.75B would be a good start :-)
https://twitter.com/GMF782/status/1557416493113085957

Don't think it's ever been 25p. I thought the high was around 15p.